Kubo Kanae, Yamamoto Kazuhiko
Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan.
Int J Rheum Dis. 2016 Aug;19(8):747-62. doi: 10.1111/1756-185X.12586. Epub 2015 Aug 10.
Immunoglobulin G4-related disease (IgG4-RD) is a regional or systemic fibro-inflammatory disease of unknown etiology. It presents a distinctive histopathological appearance of dense lymphoplasmacytic infiltrates with abundant IgG4-positive plasma cells, storiform fibrosis and obliterative phlebitis with the appearance of inflammatory swelling or tumefactive lesions. This new disease entity includes a wide variety of diseases such as Mikulicz disease, autoimmune pancreatitis, Riedel thyroiditis, interstitial nephritis and retroperitoneal fibrosis. Glucocorticoid therapy can resolve the clinical and pathological abnormalities and impaired organ function. IgG4-RD was recognized internationally in 2011, and new evidence has accumulated regarding its pathogenesis, clinical features and treatment. In this review, we outline our present understanding of IgG4-RD.
免疫球蛋白G4相关性疾病(IgG4-RD)是一种病因不明的局限性或全身性纤维炎症性疾病。它具有独特的组织病理学表现,即密集的淋巴浆细胞浸润,伴有大量IgG4阳性浆细胞、席纹状纤维化和闭塞性静脉炎,并出现炎症性肿胀或肿块样病变。这种新的疾病实体包括多种疾病,如米库利奇病、自身免疫性胰腺炎、里德尔甲状腺炎、间质性肾炎和腹膜后纤维化。糖皮质激素治疗可使临床和病理异常以及受损的器官功能得到缓解。IgG4-RD于2011年在国际上得到认可,关于其发病机制、临床特征和治疗的新证据不断积累。在这篇综述中,我们概述了目前对IgG4-RD的认识。